The Joint United Nations Program on HIV/AIDS (UNAIDS) has adopted the Sustainable
Development Goals (SDGs) to end the HIV/AIDS epidemic by 2030. Several factors related …

Introduction Human T-cell lymphotrophic virus type-1 (HTLV-1) and human
immunodeficiency virus (HIV-1) co-infection occur in many populations. People living with …

Background Human T-Lymphotropic Virus type 1 (HTLV-1) is a human oncoretrovirus that
infects at least 5 to 10 million people worldwide and is associated with severe diseases …

The article focuses on the 2023 HTLV European Research Network (HERN) meeting, which
discussed the silent pandemic of HTLV-1 infection. Topics include the origin and prevalence …

Background Recent data have shown that HTLV-1 is prevalent among HIV positive patients
in Mozambique, although the impact of HTLV-1 infection on HIV disease progression …

Background Individuals with human T-cell lymphotrophic virus type-1 (HTLV-1)/HIV-1
coinfection have been demonstrated to undergo CD4+ lymphocytosis even in the face of …

Background Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1
infected people, but long-term follow-up data are rare. We compared mortality rates of HIV-1 …

HTLV-1 infection is considered as highly endemic in central Africa. Thirty years ago, a first
epidemiological study was performed in Gabon, central Africa, and revealed that the …

The prevalence of human T-cell lymphotropic viruses types 1 and 2 (HTLV-1/2) in
Mozambique is not known. The present study examined blood samples from 208, 226, and …

Background Human T‐cell lymphotropic virus type 1 (HTLV‐1), the causative agent of adult
T‐cell leukaemia/lymphoma (ATL) and HTLV‐1‐associated myelopathy/tropical spastic …